SAN DIEGO, Nov. 21, 2013 (GLOBE NEWSWIRE) -- Lithera, Inc., a clinical stage pharmaceutical company focused on lifestyle and medical indications in aesthetic medicine and ophthalmology, today announced the appointment of Lincoln Krochmal, M.D., as Chief Medical Officer. This appointment reflects the continued growth of Lithera as it prepares to enter late-stage clinical trials and to commercialize its lead product candidate, LIPO-202 (Salmeterol Xinafoate for Injection).
Help employers find you! Check out all the jobs and post your resume.
